Fungal Diagnostics – Page 2

An Optimized In-House Protocol for Cryptococcus neoformans DNA Extraction from Whole Blood: Comparison of Lysis Buffer and Ox-Bile Methods

mycolabadmin

Researchers developed a simple, low-cost method to extract DNA from Cryptococcus neoformans fungal cells found in blood samples. The new method uses a homemade salt buffer solution instead of expensive commercial kits, making it accessible to laboratories in developing countries. Testing showed this method works better than an alternative ox-bile method, detecting very small numbers of fungal cells. This breakthrough could help doctors more quickly diagnose a serious fungal infection called cryptococcal meningitis in resource-limited settings.

Clinical aspects and recent advances in fungal diseases impacting human health

mycolabadmin

Fungal infections affect over a billion people worldwide and are becoming harder to treat due to growing resistance to antifungal medications. The review discusses major challenges in detecting and treating these infections, including difficulty in diagnosis and limited awareness among healthcare providers. New antifungal drugs are being developed and approved to address these challenges, but a comprehensive approach involving better awareness, improved testing, and responsible medication use is needed.

Usefulness of Serum as a Non-Invasive Sample for the Detection of Histoplasma capsulatum Infections: Retrospective Comparative Analysis of Different Diagnostic Techniques and Quantification of Host Biomarkers

mycolabadmin

This study examined whether using blood serum samples is practical for diagnosing histoplasmosis, a serious fungal infection caused by Histoplasma capsulatum. Researchers tested four different diagnostic methods on serum samples from patients with histoplasmosis, varying in severity and immune status. They found that combining multiple testing methods provided the best results, with different techniques working better depending on whether patients had weakened immune systems from HIV or were otherwise healthy. The study also measured immune system chemicals called cytokines and found elevated levels in infected patients, suggesting these could help predict disease severity.

Monoclonal Antibodies Can Aid in the Culture-Based Detection and Differentiation of Mucorales Fungi—The Flesh-Eating Pathogens Apophysomyces and Saksenaea as an Exemplar

mycolabadmin

This research developed a special antibody test to quickly identify deadly flesh-eating fungi called Apophysomyces and Saksenaea, which cause serious skin and soft tissue infections. These fungi are difficult to identify because they don’t form spores on standard laboratory media. The new test uses a simple method combining antibody detection with a rapid lateral-flow test, similar to a COVID-19 test, making diagnosis faster and more reliable in hospitals that don’t have access to expensive equipment.

The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective

mycolabadmin

Fungal infections affect over a billion people worldwide but are often overlooked in healthcare. The World Health Organization recently created a priority list of dangerous fungi to help doctors and researchers focus their efforts. This review discusses how this list can improve diagnosis, testing, and treatment of fungal infections across Europe, while also highlighting the need for better training and awareness among healthcare workers.

Identification of fungal agents isolated from burn lesions using mycological and molecular methods in patients admitted to Velayat burn hospital in Rasht city during 2022–2023

mycolabadmin

Researchers studied fungal infections in burn patients at a hospital in Iran and found that non-albicans Candida fungi, particularly a species called Candida parapsilosis, were the most common culprits. Using laboratory cultures and genetic testing, they identified 101 fungal infections out of 380 burn patients. Understanding which fungi cause these infections is important for doctors to choose the right treatment and improve patient outcomes.

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

Researchers surveyed infectious disease doctors across the United States about their use of a simple blood test that detects cryptococcal fungal infections in HIV patients before symptoms appear. The test, called cryptococcal antigen (CrAg) screening, can prevent serious illness and death if caught early, but the survey found that many doctors are not using it consistently. About 42% of doctors were unsure about the benefits of the test, and another 32% were confused about current screening recommendations, revealing a need for better education about this important preventive tool.

Identification of Challenging Dermatophyte Species Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

mycolabadmin

This study shows that MALDI-TOF mass spectrometry is an effective method for quickly identifying skin fungal infections caused by dermatophytes. By combining commercial reference databases with a custom library created from local isolates, researchers achieved 90.7% accurate identification compared to only 16.1% using the commercial database alone. This improved method could help doctors diagnose and treat fungal skin infections more quickly and accurately in clinical laboratories.

Evaluation of the DendrisKIT®DP for the Diagnosis of Superficial Fungal Infections

mycolabadmin

Researchers evaluated a new rapid test called DendrisKIT®DP that can identify skin, nail, and hair fungal infections much faster than traditional methods. The test uses PCR technology combined with artificial intelligence to detect 13 different fungal species directly from patient samples in less than 48 hours, compared to traditional cultures that take up to 4 weeks. The test showed good accuracy with 84% sensitivity and 89% specificity, and when combined with traditional methods, provides a better overall diagnostic strategy for fungal infections.

First Step on the Way to Identify Dermatophytes Using Odour Fingerprints

mycolabadmin

Researchers have developed a new method to quickly identify fungal skin infections caused by dermatophytes by detecting the unique smells (volatile compounds) they produce. Instead of waiting days or weeks for culture-based tests, this approach uses advanced chemical analysis to create a fingerprint of the fungus based on its odor. The study analyzed 47 different dermatophyte strains and found that each species and even individual strains have distinctive chemical signatures, which could one day allow doctors to diagnose infections rapidly using portable devices similar to electronic noses.

Research Topic: Fungal Diagnostics